BioInformant

Your Global Leader in Stem Cell Market Research

Organicell Regenerative Medicine: Advances of Exosome-Based Therapeutics in the Clinic

By Leave a Comment

Author: Greta Gohring (Research Assistant, Organicell Regenerative Medicine)

Regenerative Medicine is a rapidly expanding sector of biotechnology with numerous innovative therapeutics. Regenerative medicine encompasses a multitude of specialties such as orthopedics, immunology, and cardiology, while following common trends within the fields of tissue and cell engineering. In contrast to common symptom-targeting therapeutics, which temporarily relieve and subdue conditions, regenerative medicine is designed to reprogram damaged or diseased tissues back to a healthy state. Through reprogramming, regenerative medicine has the potential to provide long-term effects in chronic and reoccurring symptomatic diseases. [Read more…]

Can Stem Cells Be Used In Kidney Cancer Treatments?

By Leave a Comment

Find out how a stem cell transplant can contribute to kidney cancer treatment in the article below. In this article:

  1. What Is Kidney Cancer?
  2. Who is at Risk of Kidney Cancer?
  3. Does Stem Cell Therapy Provide a Future for Kidney Cancer Treatment?
  4. How Do Stem Cells Work in Treating Renal Cancer?
  5. Is There a Risk for Stem Cell Transplant in Treating Kidney Cancer?

[Read more…]

History of CAR-T Cell Therapy Spans 60+ Years

By 1 Comment

The groundbreaking approvals of two CAR-T therapies in 2017 was the climax of more than sixty years of devoted research. In the 1950s, the discovery of bone marrow transplantation laid the foundation for developing CAR-T therapy, as it was the first time that living cells were infused into blood cancer patients for the control of cancer.

As early as 1900s, researchers were becoming aware that T cells could easily search, recognize and kill cancer cells. To do this, the cells need a “guide” to direct them to the tumors, and thus, antibodies emerged as a valuable scientific and medical tool. [Read more…]

Placental Stem Cells – Interview with Dr. Ornella Parolini of IPLASS

By 4 Comments

In this interview with Dr. Ornella Parolini, Director of the E. Menni Research Center in Italy, we discussed her pioneering research on human placental stem cells. Her research is focused on the immunomodulatory and anti-inflammatory properties of amniotic and chorionic membrane cells. She is also President of the International Placenta Stem Cell Society (IPLASS), making her a globally recognized expert.

In addition to Dr. Robert Harari who holds a wide range of placental stem cell patents, Dr. Parolini is one of the world’s leading experts on placental stem cells and their therapeutic applications.

In this article:

[Read more…]

Shopping cart0
There are no products in the cart!
Continue shopping
0